RECURRENCE RISK IN CHD

被引：5
|
作者：
ZETTERQVIST, P [1 ]
机构：
[1] KAROLINSKA HOSP,S-10401 STOCKHOLM,SWEDEN
来源：
CIRCULATION | 1977年 / 55卷 / 03期
关键词：
D O I：
10.1161/01.CIR.55.3.555
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：555 / 555
页数：1
相关论文
共 50 条
  • [21] High triglycerides associated with risk of stroke in CHD
    不详
    GERIATRICS, 2002, 57 (02) : 13 - 13
  • [22] DIETARY LIPIDS AS RISK-FACTORS FOR CHD
    SHEKELLE, RB
    PAUL, O
    SHRYOCK, AM
    STAMLER, J
    JOURNAL OF THE ROYAL COLLEGE OF PHYSICIANS OF LONDON, 1983, 17 (01): : 69 - 70
  • [23] Ziprasidone vs olanzapine: Contrasts in CHD risk
    Harrison, DJ
    Cheli, A
    Loebel, A
    Murray, S
    SCHIZOPHRENIA BULLETIN, 2005, 31 (02) : 562 - 563
  • [24] Ziprasidone vs olanzapine: Contrasts in CHD risk
    Cheli, A
    Harrison, D
    Loebel, A
    Murray, S
    EUROPEAN PSYCHIATRY, 2005, 20 : S65 - S66
  • [25] Clinical depression and inflammatory risk markers for CHD
    Miller, GE
    Stetler, CA
    Carney, RM
    Freedland, KE
    Banks, WA
    PSYCHOSOMATIC MEDICINE, 2002, 64 (01): : 101 - 101
  • [26] Role of the leukocyte count in CHD risk assessment
    Nature Clinical Practice Cardiovascular Medicine, 2005, 2 (1): : 7 - 7
  • [27] Impact of risk factor modification on the CHD process
    Fuster, V
    AMERICAN JOURNAL OF MANAGED CARE, 1997, 3 : S32 - S35
  • [28] Abdominal fat puts women at risk for (CHD)
    不详
    JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION, 1999, 91 (03) : 125 - 125
  • [29] Predicting CHD risk in patients with diabetes mellitus
    Yeo, WW
    Yeo, KR
    DIABETIC MEDICINE, 2001, 18 (05) : 341 - 344
  • [30] Ziprasidone vs olanzapine: Contrasts in CHD risk
    Leaderer, M
    Harrison, DJ
    Loebel, A
    Murray, S
    VALUE IN HEALTH, 2004, 7 (03) : 318 - 318
12345